TRPC6-dependent regulation of BDNF or endocannabinoids has not been precisely studied in AD models or at least in hippocampal neurons, thus their contribution to the positive influence of TRPC6 agonists in AD-affected brains remains controversial. This evidence concerns the gene BDNF and Alzheimer disease.